Previous studies demonstrated that PINK1/Parkin dependent mitophagy can facilitate chemotherapy resistance in ovarian cancer (32), hepatic carcinoma (33, 34), breast adenocarcinoma (35) and lung cancer (36). The gene discussed is PINK1; the disease is hepatocellular carcinoma.